The global CAR T-cell therapy market has witnessed significant expansion in recent years. This movement is driven by the rising prevalence of cancer, advancements in therapy, and a rapid demand for successful treatment options. The market is anticipated to arrive at a value of hundreds of billions of dollars by the end of the decade, with a growth